Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Ozair, Ahmad
Khosla, Atulya Aman
Patel, Neha
Elson, Paul
Murphy, Erin Sennett
Yu, Jennifer S.
Chao, Samuel T.
Suh, John H.
Stevens, Glen
Peereboom, David M.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin Fdn, Solon, OH USA
[4] Cleveland Clin, Brunswick Urgent Care, Cleveland, OH USA
[5] Case Western Reserve Univ, Dept Radiat Oncol, Rose Ella Burkhart Brain Tumor & Neuro Oncol Ctr, Cleveland Clin,Lerner Coll Med, Cleveland, OH USA
[6] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH USA
[7] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2022, 24 : 73 - 73
  • [32] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [34] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Ciesielski, Michael J.
    Reardon, David A.
    Abad, Ajay
    Curry, William
    Wong, Eric
    Peereboom, David
    Figel, Sheila
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry
    Liu, Song
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Khosla, Atulya
    Casucci, Danielle
    Mechtler, Laszlo
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [35] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [36] PRELIMINARY DATA FROM A MULTICENTER, PHASE II, RANDOMIZED, NONCOMPARATIVE CLINICAL TRIAL OF RADIATION THERAPY AND TEMOZOLOMIDE WITH OR WITHOUT VANDETANIB IN NEWLY-DIAGNOSED GLIOBLASTOMA
    Lee, Eudocia Quant
    Batchelor, Tracy T.
    Lassman, Andrew B.
    Schiff, David S.
    Kaley, Thomas J.
    Wong, Eric T.
    Mikkelsen, Tom
    Purow, Benjamin W.
    Drappatz, Jan
    Norden, Andrew D.
    Beroukhim, Rameen
    Weiss, Stephanie
    Alexander, Brian M.
    Sceppa, Christine
    Gerard, Mary
    Hallisey, Stephen D.
    Bochacki, Caelainn A.
    Smith, Katrina H.
    Muzikansky, Alona M.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2011, 13 : 86 - 86
  • [37] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [38] A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
    Kleinberg L.
    Ye X.
    Supko J.
    Stevens G.H.J.
    Shu H.-K.
    Mikkelsen T.
    Lieberman F.
    Lesser G.J.
    Lee E.
    Grossman S.A.
    Journal of Neuro-Oncology, 2023, 165 (3) : 499 - 507
  • [39] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S72 - S72
  • [40] A PHASE IB TRIAL OF CEDIRANIB IN ADDITION TO STANDARD TEMOZOLOMIDE AND RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Chi, Andrew S.
    Gerstner, Elisabeth R.
    Eichler, April F.
    Chea, Houng K.
    Shearer, Nancy
    Drappatz, Jan
    Wen, Patrick Y.
    Ivy, S. Percy
    Loeffler, Jay S.
    Sorensen, A. Gregory
    Jain, Rakesh K.
    Batchelor, Tracy T.
    NEURO-ONCOLOGY, 2009, 11 (06) : 946 - 947
12345